Northwest Biotherapeutics (NWBO) Preferred Dividend Payments (2016 - 2026)

Northwest Biotherapeutics' Preferred Dividend Payments history runs 7 years deep, the most recent figure standing at $331000.0 for Q1 2026.

• In Q1 2026, Preferred Dividend Payments rose 24.91% year-over-year to $331000.0; the TTM figure through Mar 2026 stood at $1.4 million (up 24.3% YoY), while the FY2025 annual figure was $1.3 million, down 7.0% from the prior year.
• Preferred Dividend Payments for Q1 2026 stood at $331000.0, up from $137000.0 in the prior quarter.
• The five-year high for Preferred Dividend Payments was $568000.0 in Q1 2024, with the low at $132000.0 in Q3 2024.
• The 4-year median for Preferred Dividend Payments is $367000.0 (2023), against an average of $373846.2.
• The sharpest annual moves came in 2024 and 2025: Preferred Dividend Payments tumbled 74.57% in 2024, then surged 167.42% in 2025.
• Northwest Biotherapeutics' Preferred Dividend Payments stood at $367000.0 in 2023, then retreated by 25.61% to $273000.0 in 2024, then tumbled by 49.82% to $137000.0 in 2025, then surged by 141.61% to $331000.0 in 2026.
• Business Quant data shows NWBO's Preferred Dividend Payments at $331000.0 in Q1 2026, $137000.0 in Q4 2025, and $353000.0 in Q3 2025.